ViroGates A/S (CPH: VIRO)
Denmark
· Delayed Price · Currency is DKK 5.90
+0.15 (2.61%)
Oct 1, 2024, 4:35 PM CET
ViroGates Revenue
ViroGates had revenue of 1.08M DKK in the quarter ending June 30, 2024, a decrease of -32.83%. This brings the company's revenue in the last twelve months to 6.90M, down -35.06% year-over-year. In the year 2023, ViroGates had annual revenue of 6.99M, down -54.02%.
Revenue (ttm)
6.90M
Revenue Growth
-35.06%
P/S Ratio
5.51
Revenue / Employee
690.30K
Employees
10
Market Cap
38.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6.99M | -8.21M | -54.02% |
| Dec 31, 2022 | 15.20M | 6.95M | 84.27% |
| Dec 31, 2021 | 8.25M | 2.89M | 54.03% |
| Dec 31, 2020 | 5.35M | 1.77M | 49.47% |
| Dec 31, 2019 | 3.58M | 267.00K | 8.05% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 1, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk A/S | 258.00B |
| Coloplast A/S | 26.30B |
| Genmab A/S | 19.02B |
| Zealand Pharma A/S | 367.97M |
| Demant A/S | 22.84B |
| H. Lundbeck A/S | 20.67B |
| H. Lundbeck A/S | 20.67B |
| ALK-Abelló A/S | 5.18B |